Literature DB >> 17256997

A chemical approach to the identification of tensin-binding proteins.

Anne-Sophie Wavreille1, Dehua Pei.   

Abstract

Many protein-protein interactions are mediated by small modular domains, which recognize short peptide motifs in their partner proteins. However, for the great majority of these domains, the identity of their partner proteins remains unknown. In this work, a chemical/bioinformatics approach has been developed to identify phosphotyrosyl (pY) proteins that bind to tensin, a protein involved in the formation of actin cytoskeleton and signal transduction. A pY peptide library was chemically synthesized and screened against the Src homology 2 (SH2) domain of tensin to identify the peptide motifs that bind to the SH2 domain. Next, protein databases were searched for proteins containing the SH2 domain-binding peptide motifs. Finally, the potential tensin-binding proteins were confirmed (or disproved) by in vitro pull-down and coimmunoprecipitation assays. This procedure identified phosphoinositide-dependent kinase-1 and downstream of tyrosine kinase 2 as novel tensin-binding proteins. In addition, a cell-permeable pY peptide was designed as tensin SH2 domain inhibitor, which caused the disruption of actin filaments in NIH 3T3 cells. This method should be generally applicable to other modular domains that recognize small peptide motifs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17256997     DOI: 10.1021/cb600433g

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  12 in total

1.  Peptide bicycles that inhibit the Grb2 SH2 domain.

Authors:  Justin S Quartararo; Pianpian Wu; Joshua A Kritzer
Journal:  Chembiochem       Date:  2012-06-11       Impact factor: 3.164

2.  Defining SH2 domain and PTP specificity by screening combinatorial peptide libraries.

Authors:  Anne-Sophie Wavreille; Mathieu Garaud; Yanyan Zhang; Dehua Pei
Journal:  Methods       Date:  2007-07       Impact factor: 3.608

3.  Cellular phosphatase activity of C1-Ten/Tensin2 is controlled by Phosphatidylinositol-3,4,5-triphosphate binding through the C1-Ten/Tensin2 SH2 domain.

Authors:  Eui Kim; Do-Hyeon Kim; Indira Singaram; Heeyoon Jeong; Ara Koh; Jiyoun Lee; Wonhwa Cho; Sung Ho Ryu
Journal:  Cell Signal       Date:  2018-08-07       Impact factor: 4.315

4.  Cytosolic delivery of peptidic STAT3 SH2 domain inhibitors.

Authors:  Robert A Cerulli; Livia Shehaj; Isidora Tosic; Kevin Jiang; Jing Wang; David A Frank; Joshua A Kritzer
Journal:  Bioorg Med Chem       Date:  2020-05-04       Impact factor: 3.641

5.  Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1.

Authors:  Tao Liu; Yu Liu; Hung-Ying Kao; Dehua Pei
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

6.  Comprehensive analysis of phosphorylation sites in Tensin1 reveals regulation by p38MAPK.

Authors:  Emily H Hall; Jeremy L Balsbaugh; Kristie L Rose; Jeffrey Shabanowitz; Donald F Hunt; David L Brautigan
Journal:  Mol Cell Proteomics       Date:  2010-08-26       Impact factor: 5.911

7.  CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation.

Authors:  Shiao-Ya Hong; Yi-Ping Shih; Tianhong Li; Kermit L Carraway; Su Hao Lo
Journal:  Cancer Res       Date:  2013-06-17       Impact factor: 12.701

8.  Tensin 2 modulates cell contractility in 3D collagen gels through the RhoGAP DLC1.

Authors:  Katherine Clark; Jonathan D Howe; Christine E Pullar; J Angelo Green; Vira V Artym; Kenneth M Yamada; David R Critchley
Journal:  J Cell Biochem       Date:  2010-03-01       Impact factor: 4.429

9.  Profiling the substrate specificity of protein kinases by on-bead screening of peptide libraries.

Authors:  Thi B Trinh; Qing Xiao; Dehua Pei
Journal:  Biochemistry       Date:  2013-07-24       Impact factor: 3.162

10.  Cyclic peptide inhibitors of HIV-1 capsid-human lysyl-tRNA synthetase interaction.

Authors:  Varun Dewan; Tao Liu; Kuan-Ming Chen; Ziqing Qian; Yong Xiao; Lawrence Kleiman; Kiran V Mahasenan; Chenglong Li; Hiroshi Matsuo; Dehua Pei; Karin Musier-Forsyth
Journal:  ACS Chem Biol       Date:  2012-02-13       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.